Publications by authors named "Rabaeus M"

Mediterranean diet is definitely one of the healthiest dietary models. Next questions are: is the traditional Mediterranean diet adapted to the modern environmental and existential conditions? Could and/or should it be "modernized" to adapt to the various geographical, environmental, ethnic, and religious characteristics? If "modernization" is required, which traditional Mediterranean foods should be imperatively conserved as they are? Alternatively, which "new" foods-not traditional or not Mediterranean-could be introduced to help people to still respect the basic healthy Mediterranean diet principles? The present article intends to help solving these new questions.

View Article and Find Full Text PDF

Metabolic syndrome is considered as mainly caused by a deleterious lifestyle (sedentarity and diet). That smoking contributes to metabolic syndrome had been suggested by several small studies and a meta-analysis. The interesting study by Slagter et al.

View Article and Find Full Text PDF

Official guidelines bring regularly the physician to consider a statin treatment in physically active individuals, including athletes. Several factors speak against such an attitude: the available risk scores are far from precise and do not sufficiently take into account lifestyle; when you correct for the level of physical activity, cholesterol loses its' predictive value; physical activity diminishing cardiovascular risk by at least a factor 2, an athlete is always at low risk. In addition, the secondary effects of statins are liable to interfere significantly with sport activities, paradoxically increasing the risk.

View Article and Find Full Text PDF

Early randomized controlled trials (RCTs) demonstrated the health benefits of omega-3 fatty acids (n-3), whereas recent RCTs were negative. We now address the issue, focusing on the temporal changes having occurred: most patients in recent RCTs are no longer n-3 deficient and the vast majority are now treated with statins. Recent RCTs testing n-3 against arrhythmias suggest that n-3 reduce the risk only in patients not taking a statin.

View Article and Find Full Text PDF
Article Synopsis
  • Some doctors give cholesterol-lowering drugs to people with type 2 diabetes, but it's unclear if they actually help prevent heart problems.
  • A review found only four good studies on this, and most of them showed that these drugs didn't really lower the risk of dying or having heart issues in these patients.
  • The review suggests changing medical guidelines since it didn’t find enough proof that these drugs are helpful for people with type 2 diabetes.
View Article and Find Full Text PDF
Article Synopsis
  • The JUPITER trial was a study that looked at a cholesterol-lowering drug and its effects on heart disease in people who didn't have heart issues and had normal or low cholesterol levels.
  • The trial was stopped early, and it showed some confusing results, like fewer strokes and heart attacks but no big change in how many people died from these issues.
  • The findings suggest using this drug to prevent heart disease might not be a good idea, and it raises questions about how commercial interests could affect research results.
View Article and Find Full Text PDF

Physical inactivity is the most important planetary reason for non-transmissible mortality. Technical developments have allowed a sedentary lifestyle. This causes health problems such as insulin resistance, atherosclerosis, heart failure and obesity.

View Article and Find Full Text PDF

To begin exploring the relationships between immunity and clinical characteristics of depressive disorders and to further investigate the association of Major Depressive Disorder with age- and severity-related alterations in T lymphocyte numbers and in response to mitogens, we investigated 53 untreated adult outpatients with DSM III-R Major Depressive Episode (MDE) and 53 healthy matched controls. The only group difference between MDE patients and matched controls was a trend (p < .06) for a decreased number of NK cells in depressed subject.

View Article and Find Full Text PDF

Because recent research reports indicated clinical and biological differences in major depression with and without comorbid Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R) panic disorder, and as altered immune measures were reported in selected subgroups of depressive patients, we investigated 51 pairs of major depressive episode (MDE) subjects, and gender- and age-matched healthy controls in order to determine if T lymphocytes number and function abnormalities were associated with Panic Disorder comorbidty. We found that those MDE subjects with DSM-III-R panic disorder (PD) had greater numbers of T cells (p less than 0.05) and PHA mitogen (p less than 0.

View Article and Find Full Text PDF